A5042827099- Pharmaceutical Economics and Policy
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical studies and practices
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical industry and healthcare
- Healthcare cost, quality, practices
- Biotechnology and Related Fields
- Alcoholism and Thiamine Deficiency
- Economic and Financial Impacts of Cancer
- Patient Safety and Medication Errors
- Anesthesia and Sedative Agents
- Healthcare Policy and Management
- Opioid Use Disorder Treatment
- Science, Research, and Medicine
- Health and Medical Research Impacts
- Intensive Care Unit Cognitive Disorders
- Safe Handling of Antineoplastic Drugs
- Medication Adherence and Compliance
- Poisoning and overdose treatments
- Antibiotic Use and Resistance
- Electronic Health Records Systems
- Emergency and Acute Care Studies
- Global Health Care Issues
- Diversity and Career in Medicine
- Biosimilars and Bioanalytical Methods
University of Utah
2016-2025
University of Utah Health Care
2015-2021
MedStar Georgetown University Hospital
2020
MedStar Washington Hospital Center
2020
Georgetown University
2020
University of Florida
2017
University of Utah Hospital
2001-2017
Brigham and Women's Hospital
2017
George Washington University
2017
The University of Texas Health Science Center at San Antonio
2016
Drug product shortages can adversely affect drug therapy, compromise or delay medical procedures, and result in medication errors.1,2 Health care professionals are increasingly concerned about the clinical effect that have on patients tremendous resources required to address shortages.3,–5 Adverse patient outcomes related shortages1,2,6,–9 prompted aggressive management strategies by health providers gained attention of Joint Commission,10 government,11,12 media.13,14 health-system finances...
Drug product shortages can adversely affect drug therapy, compromise or delay medical procedures, result in medication errors, and cause patient harm.1–38 In addition to these potential problems, healthcare professionals are also increasingly concerned about the tremendous resources required address shortages, estimated at $209 million 2013 for purchase of more-expensive substitutes alone, which excludes other significant costs (e.g., drugs purchased "off contract," therapeutic alternatives,...
Prices for some generic drugs have increased in recent years, adversely affecting patients who rely on them.To determine the association between market competition levels and change drug prices United States.Retrospective cohort study.Prescription claims from commercial health plans 2008 2013.The 5.5 years of data were divided into 11 study periods 6 months each. The Herfindahl-Hirschman Index (HHI)-calculated by summing squares individual manufacturers' shares, with higher values indicating...
Saline Shortages — Many Causes, No Simple Solution There was already a shortage of saline solution in the United States when Hurricane Maria devastated Puerto Rico, home to key manufacturer, causing problem reach critical levels. Fixing will require multifaceted approach.
The ever-vulnerable medication supply chain is being further strained by the COVID-19 pandemic. Pharmacists in all settings, including managed care, will need to prepare for a potential exacerbation of existing and new drug shortages midst unprecedented crisis. We summarize major issues, discuss mitigation strategies, call on our colleagues respond with resilience necessary protect patients. DISCLOSURES: authors declare no funding sources nor conflicts interest.
OBJECTIVE Amphetamine derivatives are first-line medications for attention-deficit/hyperactivity disorder (ADHD). Recently, there have been increasing reports of drug shortages involving amphetamine derivatives. The objective this study is to describe trends in impacting prescription METHODS Drug shortage data were retrieved from the University Utah Information Service (UUDIS) January 2001 December 2023. Using UUDIS data, we analyzed all reported derivatives, including salts,...
A health system's experience in monitoring drug shortages since 1996 within the organization and 2001 on a national level is described. Since January 1996, Drug Information Service (DIS) at University of Utah Hospitals Clinics (UUHSC) has systematically prepared written bulletins to affected practitioners when occurred. The DIS began providing information American Society Health-System Pharmacists 2001. total 224 were tracked from June 2002. All UUHSC also shortages, but only about two...
Abstract Objectives This was a study of longitudinal trends in U.S. drug shortages within the scope emergency medicine ( EM ) practice from 2001 to 2014. Methods Drug shortage data University Utah Information Service were analyzed January March Two board‐certified physicians classified based on whether they practice, are used for lifesaving interventions or high‐acuity conditions, and substitute exists its routine use care. Trends length drugs described using standard descriptive statistics...
Hundreds of drug products are currently marketed in the United States without approval from FDA. The 2006 Unapproved Drugs Initiative (UDI) requires manufacturers to remove these market or obtain FDA by demonstrating evidence safety and efficacy. Once acts against an unapproved drug, fewer remain market, potentially enabling price increases greater susceptibility shortages. There is a need for systematic study UDI's effect on prices shortages all targeted drugs.
Early evidence suggests that provisions of the Food and Drug Administration Safety Innovation Act 2012 are associated with reductions in total number new national drug shortages. However, drugs frequently used acute unscheduled care such as delivered emergency departments may be increasingly affected by Our estimates, based on reported shortages from 2001 to 2014 collected University Utah's Information Service, show although annual has decreased since act's passage, half all study period...
Shortages and sudden price increases of certain drugs may both occur emergently, with little to no warning, they can have a dramatic impact on patient care. Little data are available linking drug shortages increases. Many the same characteristics that make medications susceptible also place them at risk for These include unapproved drugs, off-patent sole-source medications, infrequently used medications. We reviewed shortage from University Utah Drug Information Service demonstrate how...
Drug shortages are a problem that has been growing in recent years. This an impact on patient outcomes and public health. Most countries have affected by diversity of drug supply chain problems.To assess explanations for differences reported the hospital setting Saudi Arabia (SA) United States (US).Data were collected May-June 2014 from Brigham Women's Hospital (BWH) 2 hospitals: King Abdulaziz University (KAUH) Faisal Specialist Research Centre (KFSHRC). Drugs classified using World Health...
At the onset of coronavirus (COVID-19) pandemic, hospitals experienced a demand surge for COVID-19–related medical care while simultaneously struggling to source prescription drugs needed manage COVID-19 patients. This is worrisome as shortfalls in supply essential can negatively impact patient outcomes. The popular press reporting on these challenges suggests that they are caused by chain disruptions. However, rigorous research relationship between pandemic and drug limited. To address this...
Context. Drug shortages have significantly increased over the past decade. There are limited data describing how impact medical toxicology of drugs. Objective. To characterize drug affecting management poisoned patients. Materials and Methods. shortage from January 2001 to December 2013 were obtained University Utah Information Service. Shortage for agents used treat poisonings analyzed. on type, formulation, reason shortage, duration, marketing, whether was available a single source...